ORGANOGENESIS HOLDINGS INC. Line of Credit Facility, Unused Capacity, Commitment Fee Percentage
ORGANOGENESIS HOLDINGS INC. (ORGO) had Line of Credit Facility, Unused Capacity, Commitment Fee Percentage of 0.25% as of 2019-03-15, per its 10-Q filed 2019-08-09.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage · last filed 2019-08-09
- 2019-03-15: Line of Credit Facility, Unused Capacity, Commitment Fee Percentage 0.25%.
| Period end | Line of Credit Facility, Unused Capacity, Commitment Fee Percentage |
|---|---|
| 2019-03-15 | 0.25% 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |